Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster Yahiya Y. Syed Adis Drug Evaluation 29 October 2018 Pages: 1031 - 1040
Adjunctive Therapies in Parkinson’s Disease: How to Choose the Best Treatment Strategy Approach Margherita FabbriMario M. RosaJoaquim J. Ferreira Therapy in Practice 15 October 2018 Pages: 1041 - 1054
Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns Zeina Al-MansourMuthalagu RamanathanJan Cerny Review Article 09 October 2018 Pages: 1055 - 1064
Evidence-Based Management of Diabetes in Older Adults Arshag D. Mooradian Review Article 10 October 2018 Pages: 1065 - 1078
Efficacy of a Standardized Oral Vitamin D Dosing Regimen in Nursing Home Residents Marlous Toren-WielemaRuth VeenhuizenEric van Roon Short Communication 22 October 2018 Pages: 1079 - 1087
Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities Matthew AlcuskyAnne L. HumeKate L. Lapane Short Communication 13 November 2018 Pages: 1089 - 1098
Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation Federico ReaGiulia Calusithe I-GrADE Investigators Original Research Article 26 October 2018 Pages: 1099 - 1108
Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures Raquel CostaBernhard SteinhoffPatrício Soares-da-Silva Original Research Article Open access 01 November 2018 Pages: 1109 - 1117
Comment on: “Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)” Maurizio Stefani Letter to the Editor 27 October 2018 Pages: 1119 - 1120
Authors’ Reply to Stefani: “Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)” Ane ErdalDagrun D. SletteboBettina S. Husebo Letter to the Editor 27 October 2018 Pages: 1121 - 1122
